Home +8801575308158

LuciAlpe 150 Mg (Alpelisib)

LuciAlpe 150mg (generically known as Alpelisib) is a targeted oral medication manufactured by Lucius Pharmaceuticals It is primarily prescribed alongside Fulvestrant to treat postmenopausal women and men with hormone receptor (HR)-positive, HER2-negative, and PIK3CA-mutated advanced or metastatic breast cancer.

WhatsApp QR

Scan to Order

Order Now +8801575308158
Dosage and Administration:

Administration: Taken orally with food, daily.

Guidance: Tablets must be swallowed whole, not chewed, crushed, or split. Dosage is determined by a healthcare provider.

  • Storage: Maintain in a dry environment at controlled room temperature (20°C to 25°C).
  • Safety: Contraindicated during pregnancy or breastfeeding. Notable side effects include potential blood sugar changes, nausea, and fatigue

Reviews

There are no reviews yet.

Be the first to review “LuciAlpe 150 Mg (Alpelisib)”

Your email address will not be published. Required fields are marked *

Scroll to Top